These results, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 guidance the idea of targeting ACKR3 as a singular approach to modulate the opioid process, which could open new therapeutic avenues for opioid-associated Diseases. The website is protected. The https:// https://jonathanv951tkc7.mdkblog.com/profile